Related by context. All words. (Click for frequent words.) 88 Genasense ® oblimersen 87 DNA RNA Medicines 86 Genasense R oblimersen 77 omecamtiv mecarbil formerly 74 CK # novel 73 Panzem R 73 apricitabine ATC 73 targeted radiotherapeutic 72 2 methoxyestradiol 72 candidate XP# 71 Genasense oblimersen sodium Injection 70 anticancer compound 70 oral prodrug 70 candidate brentuximab vedotin 70 GLP1 INT TM 70 personalized cellular immunotherapy 70 candidate Zenvia 70 PNP inhibitor 70 candidate deforolimus 70 FOLOTYN ® 69 bucindolol hydrochloride 69 investigational pharmacologically unique 69 PHX# 69 IRX 2 69 Locteron ® 69 BiovaxID TM 69 oncolytic virus therapies 69 delivers fluocinolone acetonide FA 69 mGluR5 negative 69 IMiDs ® 69 candidates bavituximab 69 ALN PCS 69 candidate Gencaro TM 69 IMiDs R 69 polysaccharide polymer 69 refractory chronic lymphocytic 69 molecular imaging radiopharmaceutical 69 candidate NGX 69 PI3K/Akt pathway inhibitor 69 orBec R oral beclomethasone 69 CDK cyclin dependent 69 XL# anticancer compounds 69 Celacade TM technology 68 arsenic trioxide injection 68 PROVENGE sipuleucel T 68 compound PMX # 68 candidate epratuzumab 68 pan histone deacetylase 68 lintuzumab SGN 68 Curaxin CBLC# 68 forodesine 68 systemic RNAi therapeutic 68 orBec ® oral beclomethasone 68 Xcytrin R 68 candidate EFAPROXYN TM 68 topically applied SEPA 68 HDL Mimetic Peptide 68 virus HCV protease inhibitor 68 EVIZON TM squalamine lactate 68 Phase #b/#a clinical 68 compound CIP FENOFIBRATE 68 investigational immunotherapy 68 liposomal formulation 67 compound INCB# 67 acetonide FA 67 ABL inhibitor 67 individualized cellular immunotherapy 67 oxybutynin ATD TM 67 CORT # 67 candidate cethromycin 67 Bifunctional Muscarinic Antagonist Beta2 67 therapy Tovaxin 67 PDX pralatrexate 67 HIV maturation inhibition 67 HCV protease inhibitor 67 candidate TNFerade biologic 67 dextofisopam 67 MEK inhibitor 67 Nicotine Conjugate Vaccine 67 subsidiaries visit http:/www.apricusbio.com 67 candidate MyVax 67 evaluating picoplatin 67 drug pipeline TAFA# 67 AAG geldanamycin analog 67 Crofelemer budesonide foam 67 oral nucleoside analogue 66 non porcine pancreatic 66 metaglidasen 66 evaluating bafetinib 66 acyclovir Lauriad R 66 IMPDH inhibitor 66 histone deacetylase HDAC inhibitor 66 trastuzumab DM1 T DM1 66 SinuNase TM 66 MEK inhibitor RDEA# 66 5 FU leucovorin 66 drug ISA# 66 PEG SN# 66 non nucleoside inhibitor 66 phase IIb clinical 66 5 HT3 antagonist 66 HGS ETR1 mapatumumab 66 lead molecular radiotherapeutic 66 VEGFR2 inhibitor 66 pseudobulbar affect PBA 66 Telik logo TELINTRA 66 Anturol ® 66 XL# XL# XL# XL# 66 Protexia ® 66 SPL# Gel vaginal microbicide 66 evaluating intravenous picoplatin 66 Personalized Immunotherapy 66 refractory gout 66 Completes Patient Enrollment 66 Survivin antagonist 66 cancer indications bafetinib 66 MEK Inhibitor 66 candidates Azedra TM 66 small molecule chemopotentiator 66 oral ridaforolimus 66 SinuNase ™ 66 CYT# potent vascular disrupting 66 hormone LHRH antagonist 66 methylnaltrexone bromide 66 IMiDs ® compound 66 novel antifolate currently 66 next generation URAT1 66 NicVAX TM 66 Panzem R NCD 66 Aganocide R 66 Aganocide 66 TRANSDUR ® 65 PrevOnco ™ 65 Intermezzo ® zolpidem tartrate 65 paclitaxel Taxol ® 65 docetaxel Taxotere R 65 telomerase inhibitor drug 65 pralatrexate injection folate analogue 65 ELADUR ™ 65 targets Galectin receptors 65 interferon gamma 1b 65 R#/MEM # 65 candidate ridaforolimus 65 sulfonylhydrazine class 65 Elagolix 65 sapropterin dihydrochloride 65 Pruvel ™ 65 LymphoStat B belimumab 65 IgG1 monoclonal antibody 65 include LibiGel ® 65 oral isotype selective HDAC 65 Selective Electrochemical Tumor Ablation 65 evaluating tivozanib 65 Zemiva TM 65 ThermoDox R 65 product Fentanyl TAIFUN 65 HepeX B TM 65 telomerase therapeutic 65 alvespimycin 65 TRO# 65 dasatinib Sprycel ® 65 orally administered inhibitor 65 PEGylated interferon 65 Anturol TM 65 forodesine hydrochloride 65 motexafin gadolinium Injection 65 Initiates Enrollment 65 recurrent metastatic ovarian cancer 65 PLK1 SNALP 65 Archexin 65 Hematide TM 65 intravesical infusion therapy 65 markets HP Acthar 65 Initiates Phase II 65 lucinactant 65 pulmonology portfolio 65 include PLX IBD 65 kidney urologic 65 Staccato loxapine 65 sapropterin dihydrochloride Tablets 65 Pruvel TM 65 generation purine nucleoside 65 product platforms AZX# 65 IMiDs 65 immunosuppressive compound 65 Ovitrelle R Serostim 65 selective androgen receptor modulator 65 Prodarsan R 65 mesylate tablets 65 TBC# 65 Annamycin 65 Perflubutane Polymer Microspheres 65 Neo Kidney Augment 65 Empatic ™ 65 candidates Azedra 65 regenerative therapies E1 INT 65 CD4 monoclonal antibody 65 CINQUIL 65 CEQ# 65 Hedgehog Pathway Inhibitor 65 systemic anaplastic large 65 Hematide ™ 65 NeuroSTAT ® 65 system REG1 consists 65 compound perifosine 65 Aganocide ® 65 SUPPRELIN R LA 65 TRANSDUR ™ 65 P#X# antagonist 65 developing Bicifadine serotonin 65 FACTIVE R gemifloxacin 65 sapacitabine CYC# 65 transcriptase inhibitor NNRTI 64 Epothilone D 64 Luveris R Ovidrel R 64 novel VDA molecule 64 Tezampanel 64 Cleviprex TM clevidipine 64 reslizumab 64 Staphylococcus aureus Immune Globulin 64 Zorbtive TM 64 non nucleoside HCV 64 investigational humanized monoclonal antibody 64 POSIDUR TM ELADUR TM 64 CTAP# Capsules 64 ALTROPANE R 64 drug GAP #B# 64 overactive bladder VANTAS R 64 Zenvia ™ 64 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 64 IMA# 64 interferon beta 1a infertility 64 candidate CRLX# 64 developing Zerenex TM 64 topical non steroidal 64 LEP ETU 64 Exherin 64 R metformin Concor 64 treat opioid induced 64 Solazed TM 64 CD# CEA 64 Proxinium TM 64 brand ciclesonide HFA 64 Intravenous Human 64 FOLFOX6 chemotherapy regimen 64 HGS ETR1 64 modified glutathione analog 64 PANVAC VF 64 candidate Lovaxin C 64 alpha folate receptor 64 REG1 Anticoagulation System 64 developing Zerenex ferric 64 nasal calcitonin product 64 PDE4 inhibitor 64 catheter occlusion 64 HGS ETR2 64 Agonist MABA program 64 please visit www.advaxis.com 64 Pivotal Phase III 64 leading oral taxane 64 KNS # 64 ALN TTR 64 hypoxia selective 64 Besivance 64 vapreotide acetate 64 PEGylated anti 64 treat male hypogonadism 64 Marqibo TM 64 Vitrasert R 64 Receives Orphan Drug Designation 64 diagnostic radiopharmaceutical 64 vinca alkaloid 64 sorafenib tablets 64 Iluvien ® 64 dextromethorphan quinidine 64 IAP inhibitor 64 OAB overactive bladder 64 SinuNase TM novel 64 Oracea TM 64 ZADAXIN ® 64 tiapamil 64 mertansine 64 relapsed refractory multiple myeloma 64 development peramivir neuraminidase 64 faropenem medoxomil 64 ADP receptor antagonist 64 custirsen 64 MAGE A3 ASCI 64 Amigal TM 64 Testosterone MDTS ® 64 biomodulator 64 IL# PE#QQR 64 ATRA IV 64 markets COLAZAL 64 Augment TM 64 proprietary polysaccharide 64 transthyretin mediated amyloidosis ATTR 64 Cetrorelix 64 ZEVALIN ® 64 Cotara R 64 GVAX R 64 oral isoform selective HDAC 64 candidate ATHX 64 ALN HPN 64 6 sulfatase 63 Vidaza ® 63 MKC# 63 Bezielle 63 OMNARIS HFA 63 Serdaxin ® 63 pipeline ImmunoGen collaborators 63 candidate Puricase 63 octreotide acetate 63 Xeloda ® 63 Regeneron Pharma 63 dihydrochloride Tablets 63 include ColorectAlert TM 63 BENLYSTA TM 63 compound ISA# 63 mitogen activated ERK kinase 63 Neo Urinary Conduit 63 successfully commercialize Iluvien 63 inflammatory autoimmune diseases 63 R Saizen R 63 Lipid Polymer Micelle LPM 63 LibiGel ® 63 Proellex TM 63 LymphoStat B TM 63 accumulate preferentially 63 R famotidine 63 Inc. NASDAQ AEZS 63 PROVENGE ® 63 SPRYCEL ® 63 Begins Dosing 63 PEGylated Fab fragment 63 evaluating satraplatin 63 TELINTRA R 63 oxybutynin ATD ™ 63 RANK Ligand inhibitor 63 cardiometabolic diseases Glucophage 63 ATPace TM 63 agonistic human 63 VIVITROL ® 63 HCV polymerase inhibitors 63 lenalidomide Revlimid R 63 memantine HCl 63 small molecule Hedgehog 63 cutaneous T 63 Phase 2b Clinical Trial 63 developing ACAPODENE 63 Intravenous CP 63 intranasal formulation 63 Phase IIb clinical trials 63 synthetic retinoid 63 Inc. AMEX YMI 63 programs AN# topical 63 signal transduction inhibitor 63 BEMA Granisetron 63 ThermoDox ® clinical 63 R vancomycin hydrochloride 63 cardiac muscle contractility 63 ApoB SNALP 63 developing ostarine selective 63 CORLUX CORT # 63 hyperphenylalaninemia HPA due 63 Hsp# Inhibitor 63 ocular formulation 63 multi kinase inhibitor 63 metabolic disorders Saizen R 63 inhibitor PPI 63 Pigment containing 63 oral ferric iron 63 novel synthetic PEGylated 63 TRIOLEX HE# APOPTONE HE# 63 dependent kinase inhibitor 63 investigational monoclonal antibody 63 PMX # PolyMedix 63 Peginterferon alfa 2b 63 targeting Inflammatory Bowel 63 Azedra 63 AzaSite Xtra 63 autologous cellular immunotherapy 63 cisplatin gemcitabine 63 oritavancin semi 63 pipeline GlycoPEG GCSF 63 alkylating agent 63 Initiates Phase III 63 TLK# 63 cancer neuroendocrine tumor 63 Androxal TM 63 Exherin TM 63 VISICOL R 63 Polymer Microspheres 63 Solution XOPENEX HFA 63 CCR9 antagonist 63 Atiprimod 63 vosaroxin 63 Onalta ™ 63 peptidic compound 63 LOMUCIN TM 63 active AKT inhibitor 63 GVAX ® 63 Vascugel 63 Aflibercept 63 dipropionate 63 efaproxiral 63 delivery polymer matrix 63 R roscovitine CDK cyclin 63 R bisoprolol Euthyrox 63 R#/MEM 63 Complicated Skin 63 rHuPH# enzyme 63 delta opioid receptor 63 ZOLINZA 63 systemically administered 63 5 HT6 63 allosteric modulator NAM 63 Nasdaq IMGN 63 OMP #R# 63 erlotinib Tarceva R 63 BXT # 63 Fortical R 63 candidates Augment ™ 63 proprietary transdermal patch 63 TKB# 63 defensin mimetic antibiotic 63 allosteric modulator 63 treat refractory angina 63 novel histone deacetylase 63 HepeX B 63 serious systemic Staphylococcal 63 novel L DOS# 63 FUSILEV enhances 63 monoclonal antibody conjugated 63 website www.celsion.com 63 docetaxel Taxotere ® 62 herpetic keratitis 62 novel emulsion formulation 62 Pivotal Phase 62 candidate HuCNS SC 62 Romiplostim 62 Glufosfamide 62 octreotide implant 62 Onalta 62 Inhalation Aerosol 62 SUCCEED trial 62 prGCD 62 aldehyde dehydrogenase ALDH2 deficiency 62 product candidate Lpathomab 62 OncoVEX GM CSF 62 PF # [002] 62 EnteroMedics proprietary neuroblocking technology 62 squalamine 62 Cyclooxygenase Inhibiting Nitric Oxide 62 Quinamed 62 CB2 selective receptor agonist 62 PEG irinotecan 62 5 fluorouracil leucovorin 62 Phase 2a clinical trials 62 Cannabinor 62 oral picoplatin 62 R sorafenib tablets 62 orally bioavailable mimics 62 RGB # 62 investigational pan BCR 62 JAK2 Inhibitor 62 lexidronam injection 62 irinotecan doxorubicin oxaliplatin paclitaxel 62 overactive bladder VANTAS 62 ONCONASE R 62 plus dacarbazine 62 JAK1 62 Phase Ib clinical trials 62 dacetuzumab SGN 62 ARRY # 62 Vidaza R 62 reversible inhibitors 62 BCG refractory carcinoma 62 vaginally administered lidocaine 62 By JAMAAL ABDUL 62 Ophena TM 62 GALNS N acetylgalactosamine 62 Chemophase 62 Presents Preclinical Data 62 mocetinostat MGCD# 62 TKM ApoB 62 Phase 2b Trial 62 highly purified pasteurized 62 HCl PEPCID ® famotidine 62 rNAPc2 62 Phase 2a Clinical Trial 62 Vicinium TM 62 PSMA ADC 62 generation Hsp# inhibitor 62 candidate Zemiva TM 62 candidate bevirimat PA 62 class anticancer quinolone 62 Injectable Suspension 62 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 62 investigational antiplatelet agent 62 Ostabolin C TM 62 OctoPlus licensed 62 Cloretazine ® 62 HCV NS5B polymerase 62 APC Targeting Technology 62 oral proteasome inhibitor 62 telaprevir dosed 62 recombinant subunit vaccine 62 trastuzumab Herceptin R 62 lomitapide 62 Alfacell proprietary ribonuclease 62 cyclobenzaprine hydrochloride extended 62 investigational hepatitis B 62 Soliris TM eculizumab 62 HuCAL PLATINUM ® CysDisplay 62 FUSILEV ® 62 BioGlue ® 62 rheumatoid arthritis thrombocytopenia 62 CRMD# 62 antibody MAb 62 Civacir 62 elotuzumab 62 HuMax TAC 62 Abiraterone acetate 62 novel orally inhaled 62 somatropin Kuvan R 62 CIP Fenofibrate 62 Kosan dependence 62 Mg Usa 62 TOCOSOL Camptothecin 62 phase III isavuconazole 62 Friedreich Ataxia FRDA 62 nilotinib Tasigna ® 62 Fludara ® 62 novel immunomodulatory 62 FDA APPROVES 62 Apoptone 62 Phase 2a clinical 62 novel DACH platinum 62 rxRNA 62 thrombin component 62 ongoing Phase 1b 62 seliciclib CYC# 62 Tovaxin TM 62 TRACON Pharmaceuticals 62 AEG# 62 serine protease inhibitor CU# 62 RELOVAIR TM 62 recombinant biopharmaceutical 62 Investigational Oral 62 Stedivaze 62 Miraxion Amarin lead 62 programs visit http:/www.bionovo.com 62 Azedra TM 62 Phase III Pivotal 62 clinical trials Archexin 62 colesevelam HCl 62 Tramiprosate ALZHEMED TM 62 Vascular Disrupting Agent 62 lesinurad 62 highly selective inhibitor 62 Meets Primary Endpoint 62 TRIOLEX ™ 62 Tyrima 62 rusalatide acetate 62 pharmacological chaperone compounds 62 PTH analogue 62 TNF Tumor Necrosis Factor 62 Liprotamase 62 Myocet 62 Hsp# inhibitor 62 Inc. Nasdaq CYCC 62 OvaRex ® MAb 62 MyVax R 62 candidate AP# 62 Perforomist ™ Inhalation Solution 62 miconazole Lauriad R 62 TM Aganocide 62 CYT# vascular disrupting 62 R memantine HCl 62 Phase III Clinical Trial 62 orally absorbed 62 Urocortin 2 62 HP Acthar Gel repository 62 enhance ApoA 62 INCB# [001] 62 Wafer polifeprosan 62 RELOVAIR ™ 62 plus fludarabine 62 TRAIL receptor antibodies 62 erlotinib Tarceva ® 62 DAVANAT R 62 NEBIDO VANTAS SUPPRELIN LA 62 prescription brands RESTYLANE 62 please visit www.middlebrookpharma.com 62 PEGylated irinotecan 62 Nexavar sorafenib tablets 62 Metastatic Melanoma 62 Restanza TM 62 Receives Fast Track 62 Initiates Clinical Trial 62 registrational trial 62 Atripla combines 62 JAK inhibitor 62 Aerosurf 62 certain protein tyrosine 62 recombinant PSMA vaccine 62 PRTX 61 include Altastaph TM 61 cosmetic cosmeceutical products 61 torezolid phosphate 61 Bicifadine 61 Soliris eculizumab 61 Solazed ™ 61 YONDELIS 61 TRX1 61 Sulonex TM 61 Generx TM 61 dimebon latrepirdine 61 Aeolus Pharmaceuticals Announces 61 Tanespimycin 61 opioid induced bowel dysfunction 61 Budesonide foam crofelemer 61 Phase 2b clinical 61 refractory cutaneous T 61 prokinetic agent 61 COLAZAL R 61 orally inhaled migraine 61 candidate REP# 61 Vitamin D analogue 61 Altera Nebulizer System 61 L Annamycin 61 triciribine phosphate monohydrate 61 xanthine oxidase inhibitor 61 immunotherapeutic agent 61 Combination REOLYSIN R 61 Lenocta TM 61 vitreoretinal disorders 61 PRT# 61 Preclinical studies suggest 61 triple VEGF receptor 61 TOCOSOL Paclitaxel 61 oral beclomethasone dipropionate 61 Cardium Therapeutics TM 61 gastro intestinal inflammation 61 Omacetaxine 61 evaluating Actimmune 61 XP# XP# 61 granted Ortec 61 Q#IR 61 oxymorphone ER 61 Drug Eluting Stent System 61 investigating pralatrexate 61 Inc. www.micromet inc.com 61 Cloretazine 61 ALV# 61 GAMMAGARD 61 Omigard 61 MAA submission 61 MOVIPREP R 61 5 lipoxygenase activating 61 Zerenex 61 TELINTRA 61 qualitative serum 61 Zalypsis 61 Bazedoxifene 61 pan HDAC inhibitor 61 Anturol 61 MKC# MKC# PP 61 #ME# 61 IMiD 61 huC# DM4 61 Phase 2b clinical trials 61 Zoraxel TM 61 antibiotic candidate Ramoplanin 61 Spiegelmer ® 61 MKC# MT 61 NEBIDO R 61 mesylate tablets approved 61 product TNFerade TM 61 stable nucleic acid 61 HCV nucleoside polymerase inhibitors 61 ATL# [001] 61 Locteron combines 61 BYETTA ® 61 metastatic castration resistant 61 Opterone R 61 ACAPODENE TM 61 Submits NDA 61 including eniluracil ADH 61 Tesetaxel 61 BrachySil TM 61 RNAi Therapeutic 61 Phase IIb Trial 61 severe hypercholesterolemia 61 utilizes InSite Vision 61 DNA methyltransferase inhibitors 61 R brand eszopiclone 61 Aurexis 61 chemotherapy induced neutropenia 61 generation URAT1 inhibitor 61 Phase IIb trials 61 Randomized Double blind 61 Alocrest 61 eniluracil 61 oral gallium 61 phenylketonuria PKU developed 61 visit www.genenews.com 61 HEPLISAV ™ 61 Brussels GLPG 61 CCX# 61 cerebral oximeter available 61 Genentech sanofi aventis 61 small molecule defensin 61 candidate Liposomal Grb 61 QUADRAMET R 61 combines bupropion 61 Presents Preclinical 61 Selzentry Celsentri 61 Vicriviroc 61 ALN TTR# 61 sodium thiosulfate STS 61 vaccine GRNVAC1 61 ALN VSP 61 GALNS 61 BRAF kinase 61 advanced carcinoid 61 external counterpulsation systems 61 Phase #/#a trial 61 using ImmunoGen TAP 61 phenylalanine ammonia lyase 61 sarcoma melanoma 61 ELADUR 61 3 registrational trial 61 hyaluronidase enzyme 61 sulodexide 61 humanized therapeutic 61 WX UK1 61 Phase IIa trials 61 product Hextend ® 61 Solzira TM 61 Zemiva ™ 61 Tengion Neo Urinary Conduit 61 evaluating T DM1 61 orally administered synthetic retinoid 61 NDA Submission 61 anthrax monoclonal antibody 61 tumor activated prodrug 61 Talabostat 61 provides RevColor RevDisplay 61 humanized anti 61 Nabi HB Intravenous 61 pharmacologically active isomer 61 candidate AQ4N 61 cetrorelix pamoate 61 OTCBB PYTO 61 Veronate R 61 signal averaging electrocardiography 61 MGCD# [001] 61 Neo Kidney Augment ™ 61 PORxin TM platforms 61 generation PNP inhibitor 61 R bendamustine hydrochloride 61 Maribavir 61 CINOD 61 Abstract Accepted 61 EOquin TM 61 APEX PD 61 Disease IBD 61 ONSOLIS TM 61 REPRONEX ® menotropins 61 Angiocept 61 Novel Oral 61 topical antifungal product 61 Patient Enrollment 61 Nasdaq XTLB 61 Traficet EN 61 generation radiolabeled antibody 61 CR# vcMMAE 61 Oral NKTR 61 ongoing Phase IIIb 61 Initiates Clinical 61 INSPIRE Trial Phase III 61 JZP 61 metastatic castrate resistant 61 Perforomist TM formoterol fumarate 61 ProLindac TM 61 HCV RNA polymerase 61 refractory Hodgkin lymphoma 61 MAb therapy 61 PORxin TM 61 Rigel R# 61 nucleotide analog 61 Azixa 61 VALSTAR R 61 Powerlink ® 61 IAP inhibitors 61 ospemifene 61 chronic eosinophilic leukemia 61 long acting muscarinic 61 TNFerade ™ 61 include VALSTAR TM 61 JAK2 inhibitor 61 Presents Positive 61 tanespimycin 61 StaphVAX R 61 Cytogen marketed 61 ALVESCO ® 61 pramlintide acetate injection 61 Bendamustine 61 LE SN# 61 HGS# 61 Exelixis compounds 61 Untreated fistula 61 topical gel formulation 61 TRAIL receptor antibody 61 HCV nucleotide polymerase inhibitor 61 SENOMYX 61 human C1 inhibitor 61 vinorelbine tartrate 61 multicenter Phase III 61 Targeted Chemotherapy 61 particularly SANCTURA XR 61 Xcellerated T Cells 61 urocortin 2 61 proven DuraSite ® 61 Locked Nucleic Acid LNA 61 induced macular edema 61 Luveniq 61 www.polymedix.com 61 MP4 molecule 61 SILENOR TM 61 Foradil Aerolizer 61 HYVISC ® treatment 61 Sapacitabine 61 RDEA# 61 candidate Hematide TM 61 signal detection CTSD 61 balsalazide disodium 61 VitiGam 60 Phase IIb Clinical Trial 60 cysteamine bitartrate 60 cinacalcet HCl 60 Initiate Clinical Trial 60 novel proprietary KL4 60 gemcitabine cisplatin 60 Kuvan R 60 Resten NG 60 TPI ASM8 60 granisetron formulated 60 rhIGF-I/rhIGFBP-3 60 Allovectin 7 60 dasatinib Sprycel 60 PRNewswire FirstCall Genta Incorporated 60 BENLYSTA ® 60 CORTOSS R 60 HCD# [002] 60 alvimopan 60 REG1 60 4SC AG ISIN DE# 60 Application BLA 60 Pharma Merck Serono 60 Pyridorin 60 pentadentate logo R 60 Combivir Kivexa 60 R MSCRAMM 60 chemosaturation 60 Alzhemed TM 60 Ceflatonin R 60 inhaled formulation 60 non peptidic protease 60 RECOTHROM R 60 DURECT proprietary 60 PrevOnco 60 TAXUS Element Stent System 60 Potassium Chloride Sodium Ascorbate 60 Randomized Phase 60 BioMarck 60 systemic immunosuppressive drugs 60 Nasdaq GNTA 60 Protease Inhibitor 60 cortisol synthesis 60 DPX Survivac 60 Phase 2a trial 60 TNFerade TM 60 evaluating pirfenidone 60 % uracil topical 60 refractory AML 60 worsening thrombocytopenia 60 histone deacetylase inhibitor 60 Treatment IND 60 CYP#A# CYP#D# 60 Suppository Hydrocortisone Acetate Rectal 60 Tiuxetan 60 sulfonylurea glimepiride 60 AVASTIN 60 By JENNIFER LEARN 60 PRNewswire FirstCall Aeterna Zentaris 60 Lisofylline LSF 60 HDAC Inhibitor 60 tezampanel 60 GATTEX ® 60 cetuximab Erbitux R 60 drug conjugate 60 clinical trials Archexin ® 60 CIP TRAMADOL ER 60 MOR# 60 http:/www.celgene.com 60 THR beta agonist 60 low toxicity bioscience 60 platinum chemotherapeutic 60 treat chronic sinusitis 60 S1P antibody 60 Mylan Receives Approval 60 apoptosis proteins 60 MelaFind R 60 Xanafide 60 Locteron exclusively 60 Epratuzumab 60 Dapagliflozin 60 silicon carbide SiC gallium 60 Completes Enrollment 60 Entereg R 60 DATA ARE FORWARD 60 Simulect 60 Kit CD# positive 60 plus Copegus R 60 zolpidem tartrate sublingual tablet 60 Pharmos proprietary 60 commercializing oxidized glutathione 60 Granted Orphan Drug 60 label Lipofen R 60 Voreloxin 60 coronary stent merged 60 oral dual endothelin 60 ALN VSP Phase 60 Nasdaq EPCT 60 PROGENSA R 60 CIMZIA TM 60 malignant mesothelioma Alfacell 60 MBP# [001] 60 acid phosphatase PAP 60 Adnectin 60 QNEXA ® 60 phase IIb trial 60 small molecule thrombopoietin 60 Zenvia TM 60 Kuvan TM sapropterin 60 sodium glucose transporter 60 compound KOS 60 neuro inflammatory disorders 60 R PEG uricase 60 bevacizumab Avastin ® 60 Xyfid TM 60 MuGard TM 60 Inc. OTCBB BVTI 60 KL4 Surfactant 60 www.incyte.com 60 MSCRAMM ® 60 APF# 60 MCSP respectively 60 candidate Zemiva 60 samarium Sm 60 specific ZFP Nucleases 60 AzaSite Plus 60 TM pralatrexate injection 60 oral rivaroxaban 60 cell lymphoma CTCL 60 anti botulism antibody 60 Kamada AAT 60 include Healive 60 researches develops licenses 60 Announces Poster Presentations 60 Panzem ® 60 Amplimexon 60 Targanta Therapeutics Corporation 60 HDL Selective Delipidation 60 molecular chaperone regulation 60 LOW PRICE STOCK 60 Nventa proprietary CoVal 60 investigational oral hepatitis C 60 RiVax 60 * olmesartan medoxomil 60 pharmacogenomic translational research 60 Ketotransdel ® 60 liprotamase 60 Receives Orphan Drug 60 investigational oral inhibitor 60 adjuvant GIST 60 Serostim ® 60 BY RYAN ERNST 60 AN# topical anti 60 mRNA antagonists 60 Phase Ib study 60 novel RNAi therapeutics 60 personalized immunotherapy 60 treats acute lymphoblastic 60 2 inhibitor CYT# 60 website http:/www.celsion.com